%0 Journal Article
%T Clinical Observation of Hemodynamic and Cerebral Protective Effects of Different Doses of Dexmedetomidine in Patients with Traumatic Brain Injury
%A Jiacai Dong
%A Lei Liu
%A Jingwei Liu
%A Yanling Peng
%J Journal of Biosciences and Medicines
%P 146-151
%@ 2327-509X
%D 2023
%I Scientific Research Publishing
%R 10.4236/jbm.2023.112010
%X Background: Patients with craniocerebral trauma may suffer ischemic brain injury and neurological dysfunction due to immune inflammation and neuroendocrine reactions. Dexmedetomidine (Dex) is one of the commonly used anesthetic drugs in clinic. Studies have shown Dex has the function of protecting brain nerves and inhibiting inflammation. However, there are few studies on the effects of different doses of dexmedetomidine on patients undergoing surgery. The purpose of this study is to observe the effects of different doses of Dex on hemodynamics and brain protection in patients undergoing brain trauma surgery. Materials and Methods: Eighty patients with craniocerebral trauma surgery were randomly divided into study group (group A, n = 40) and control group (group B, n = 40) by random number table method. Dex pump volume was 0.5 ¦Ìg/kg/h in group A and 1.0 ¦Ìg/kg/h in group B. Heart rate (HR) and mean arterial pressure (MAP) were recorded before anesthesia induction (T0), immediately after endotracheal intubation (T1) and at the end of operation (T2). The serum levels of central nervous system specific protein (S-100¦Â) and neuron specific enolase (NSE) were measured and compared between the two groups at T0 and T2. Results: HR and MAP in group A were significantly higher than those in group B at T2, and the difference was statistically significant (P < 0.05). The levels of HR and MAP in the same group were significantly lower in T1 and T2 than in T0, and the difference was statistically significant (P < 0.05). The concentrations of S-100¦Â and NSE in both groups at T2 were lower than those at T0, and the concentrations of S-100¦Â and NSE in group A were significantly lower than those in group B at T2 (P < 0.05). Conclusions: 0.5 ¦Ìg/kg dose of Dex is stable in hemodynamics and has a better protective effect on brain function in patients with traumatic brain injury.
%K Dexmedetomidine
%K Craniocerebral Trauma
%K Brain Function
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=123112